[
    [
        {
            "time": "",
            "original_text": "长春高新(000661.SZ)：子公司取得成都信立泰重组人促卵泡激素-CTP融合蛋白注射液相关权益",
            "features": {
                "keywords": [
                    "长春高新",
                    "子公司",
                    "成都信立泰",
                    "重组人促卵泡激素",
                    "CTP融合蛋白注射液",
                    "相关权益"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "长春高新(000661.SZ)：子公司取得成都信立泰重组人促卵泡激素-CTP融合蛋白注射液相关权益",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 10
            }
        },
        {
            "time": "",
            "original_text": "长春高新：子公司取得成都信立泰重组人促卵泡激素-CTP融合蛋白注射液相关权益",
            "features": {
                "keywords": [
                    "长春高新",
                    "子公司",
                    "成都信立泰",
                    "重组人促卵泡激素",
                    "CTP融合蛋白注射液",
                    "相关权益"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "长春高新：子公司取得成都信立泰重组人促卵泡激素-CTP融合蛋白注射液相关权益",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 10
            }
        }
    ]
]